| Dr David A Oppenheimer, MD | |
|
1100 Balsam Ave, Boulder, CO 80304-3404 | |
| (303) 440-2273 | |
| Not Available |
| Full Name | Dr David A Oppenheimer |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 45 Years |
| Location | 1100 Balsam Ave, Boulder, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700851250 | NPI | - | NPPES |
| 300048617 | Other | CO | BRI MEDICARE RAILROAD |
| 01252584 | Medicaid | CO | |
| 300061061 | Other | CO | DMSO CO MEDICARE RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 25258 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Boulder Community Health | Boulder, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boulder Radiologists Inc P C | 4183510274 | 15 |
News Archive
In a development that could have significant ramifications for the nation's health care system, Baby Boomers may well be entering their 60s suffering far more disabilities than their counterparts did in previous generations, according to a new UCLA study. The findings, researchers say, may be due in part to changing American demographics.
To determine whether healthy food could help low-income people better control their diabetes, a pilot study by UC San Francisco and Feeding America tracked nearly 700 people at food banks in California, Texas and Ohio over two years.
The U.S. Department of Health and Human Services announced today that The University of Texas Health Science Center at Houston (UTHealth) has been awarded $15.3 million to establish a Health Information Technology Regional Extension Center (REC).
Combining intratumoral electroporation of interleukin-12 (IL-12) DNA (tavokinogene telseplasmid, or TAVO) with the immune checkpoint inhibitor pembrolizumab (Keytruda) led to clinical responses in patients with immunologically quiescent advanced melanoma, according to results from a phase II trial.
Caraco Pharmaceutical Laboratories, Ltd. reports receipt of a proposal from Sun Pharmaceutical Industries Ltd. ("Sun") and Sun Pharma Global, Inc ("Sun Global") for a going private transaction by which Sun, Sun Global, and/or one or more of their affiliates would acquire all of the outstanding shares of Caraco common stock not held by Sun or Sun Global for a per share consideration of $4.75 in cash. This represents a 5% premium over the closing price of Caraco Common Stock on Dec 2, 2010.
› Verified 5 days ago
| Entity Name | Boulder Radiologists Inc P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891756813 PECOS PAC ID: 4183510274 Enrollment ID: O20040225000774 |
News Archive
In a development that could have significant ramifications for the nation's health care system, Baby Boomers may well be entering their 60s suffering far more disabilities than their counterparts did in previous generations, according to a new UCLA study. The findings, researchers say, may be due in part to changing American demographics.
To determine whether healthy food could help low-income people better control their diabetes, a pilot study by UC San Francisco and Feeding America tracked nearly 700 people at food banks in California, Texas and Ohio over two years.
The U.S. Department of Health and Human Services announced today that The University of Texas Health Science Center at Houston (UTHealth) has been awarded $15.3 million to establish a Health Information Technology Regional Extension Center (REC).
Combining intratumoral electroporation of interleukin-12 (IL-12) DNA (tavokinogene telseplasmid, or TAVO) with the immune checkpoint inhibitor pembrolizumab (Keytruda) led to clinical responses in patients with immunologically quiescent advanced melanoma, according to results from a phase II trial.
Caraco Pharmaceutical Laboratories, Ltd. reports receipt of a proposal from Sun Pharmaceutical Industries Ltd. ("Sun") and Sun Pharma Global, Inc ("Sun Global") for a going private transaction by which Sun, Sun Global, and/or one or more of their affiliates would acquire all of the outstanding shares of Caraco common stock not held by Sun or Sun Global for a per share consideration of $4.75 in cash. This represents a 5% premium over the closing price of Caraco Common Stock on Dec 2, 2010.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David A Oppenheimer, MD 36 Garden Ctr, Broomfield, CO 80020-1776 Ph: (303) 465-0401 | Dr David A Oppenheimer, MD 1100 Balsam Ave, Boulder, CO 80304-3404 Ph: (303) 440-2273 |
News Archive
In a development that could have significant ramifications for the nation's health care system, Baby Boomers may well be entering their 60s suffering far more disabilities than their counterparts did in previous generations, according to a new UCLA study. The findings, researchers say, may be due in part to changing American demographics.
To determine whether healthy food could help low-income people better control their diabetes, a pilot study by UC San Francisco and Feeding America tracked nearly 700 people at food banks in California, Texas and Ohio over two years.
The U.S. Department of Health and Human Services announced today that The University of Texas Health Science Center at Houston (UTHealth) has been awarded $15.3 million to establish a Health Information Technology Regional Extension Center (REC).
Combining intratumoral electroporation of interleukin-12 (IL-12) DNA (tavokinogene telseplasmid, or TAVO) with the immune checkpoint inhibitor pembrolizumab (Keytruda) led to clinical responses in patients with immunologically quiescent advanced melanoma, according to results from a phase II trial.
Caraco Pharmaceutical Laboratories, Ltd. reports receipt of a proposal from Sun Pharmaceutical Industries Ltd. ("Sun") and Sun Pharma Global, Inc ("Sun Global") for a going private transaction by which Sun, Sun Global, and/or one or more of their affiliates would acquire all of the outstanding shares of Caraco common stock not held by Sun or Sun Global for a per share consideration of $4.75 in cash. This represents a 5% premium over the closing price of Caraco Common Stock on Dec 2, 2010.
› Verified 5 days ago
Francis Ignatius Donahue, D.O. Radiology Medicare: Not Enrolled in Medicare Practice Location: 770 12th St, Boulder, CO 80302 Phone: 952-595-1100 Fax: 612-294-4903 | |
Dr. Gustavo L Isuani, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4747 Arapahoe Ave, Boulder, CO 80303 Phone: 303-465-0401 | |
Patrick Richard, M.D./M.P.H. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4715 Arapahoe Ave, Boulder, CO 80303 Phone: 303-285-2000 Fax: 303-385-2090 | |
Dr. Paul D King, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4747 Arapahoe Ave, Boulder, CO 80303 Phone: 303-415-7500 | |
Dr. Dai Thi Hoang, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 4919 10th St, Boulder, CO 80304 Phone: 952-595-1100 Fax: 952-942-3361 | |
Natalia Gaulke, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1333 Iris Ave, Boulder, CO 80304 Phone: 937-723-3248 | |
Robert E Helgans, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1100 Balsam Ave, Radiology, Boulder, CO 80304 Phone: 303-465-0401 |